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1. Introduction–objective
Hydrometrocolpos is a rare congenital anomaly formedbycystic
dilatation of vagina and uterus due to conditions like imperfo-
rated hymen, distal vaginal atresia or transverse vaginal septum
[1]. CA 19-9 is widely used as a tumor marker for cancers of the
pancreas, stomach, colon, cholangial duct, ovaries, endometrium,
and lung (adenocarcinoma). However, several benign conditions
are also known to increase serum CA 19-9 levels [2]. CA 125 is an
antigenic determinant widely used for screening of ovarian, pan-
creatic, breast, colon and lung cancers. It also increases in some
benign and physiological conditions like pregnancy, menstruation
and endometriosis [2].
2. Case
The baby was born to 28 years old healthy mother in the 38th
gestational week by cesarean section with an Apgar score at 1 and
5min were 8 and 9, respectively. The birthweight, height and head
circumference were 3940g (>90p), 50 cm (50–75p) and 34.8 cm
(50–75p), respectively. In the prenatal period the newborn was
diagnosedwithgiant cysticmass thatﬁlls theall the abdominal cav-
ity and amniotic ﬂuid volumewas normal. In preliminary diagnosis
bilateral polycystic kidneys was reported. After the delivery, the
patient was intubated because of respiratory failure. In the follow-
up of patient requiring mechanical ventilation support with low
pressure and there is good ventilation on chest radiograph we did
not accept pulmonary hypoplasia. The main cause of intubation
accepted as the compression of abdominal mass.
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Laboratory data (white cell count, C-reactive protein, biochem-
ical tests) were normal. Abdominal examination revealed a grossly
enlarged mass. Abdominal ultrasound showed a cystic structure
posterior to the urinary bladder measuring 61×46×77mm, with
a thick wall structure and anechoic ﬂuid level, and dilatation of
ureters (Fig. 1). The renal collecting system had grade 2 pelvi-
caliceal ectasia on ultrasound. Abdominal computed tomography
conﬁrmed the presence of a cystic structure in the uterine com-
partment (Fig. 2).
Theurinary outﬂowdecreased in thepostnatal 12thhour,which
was thought to be compression by the mass and thus 400ml of
ﬂuid was aspirated underwent ultrasound guided percutaneous
drainage. Biochemical, cytological and microbiological analysis of
the drainage ﬂuid revealed no pathology. Among the tests per-
formed for differential diagnosis, levels of alpha-fetoprotein and
beta-hCGwerenormal but serumCA19-9 levelwas110.1u/ml (ref-
erence value: <27u/ml) and CA 125 levelwas 278.7u/ml (reference
value: <35u/ml).
The urinary system was found to be normal but distal vagi-
nal atresia was found with cystoscopy. Diagnostic laparoscopy
revealed hydrometrocolpos. The drainage level decreased and
ceased on the 7th day and abdominal distention did not recur. On
the 8th day the levels of CA 19.9 and CA 125 turned back to nor-
mal (17u/ml and 21u/ml respectively). In the follow-up of patient
requiring mechanical ventilation support with low pressure was
discontinued on the eighth day.
3. Discussion
Hydrometrocolpos is a rare congenital anomaly with an esti-
mated incidence of 0.1–3.8 % (3). During the newborn period the
incidence is much lower, around 0.006% [1]. The condition occurs
as a result of accumulation of cervical and vaginal secretions due
to the obstruction of vaginal outlet [1]. Most cases present with
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Fig.1. Transabdominal sonography, dilatation of ureters.
Fig. 2. CT scan shows a well-deﬁned cystic mass in the pelvis.
abdominal mass, recurrent urinary tract infections or primary
amenorrhea in the pubertal period. In the neonatal period it may
present with abdominal mass, recurrent urinary tract infection,
sepsis, obstructive uropathy and respiratory failure [3,4].
CA 19-9 is widely used as a tumor marker for pancreatic,
colon, ovarian, endometrial and lung carcinoma. However sev-
eral benign conditions such as inﬂammatory or proliferative
diseases (cholangitis, pancreatitis, bronchial cyst, bronchiecta-
sis, pulmonary ﬁbrosis, endometriosis, pregnancy and ovarian
cysts), ductal obstructions (pancreatic and choledochal) and
chronic diseases (hepatitis, glomerulonephritis, diabetes mellitus,
hemodialysis, peritoneal dialysis) also increase serum CA 19-9 lev-
els [2,5].
CA 125 is also used as a tumor marker for ovarian, pancreatic,
breast, colon and lung carcinomas. Also some other physiologic
conditions such as pregnancy andmenstruation can cause elevated
serum CA 125 levels [2].
In a study which evaluated patients with CA 125 levels
over 1000u/ml; 37% of patients had non-malignant gynecologi-
cal disease (43.9% endometriosis, 12.2% adenomyosis, 9.7% pelvic
inﬂammatory disease, 7.3% uterine leiomyoma, 2.4% imperforated
hymen). However serum CA 125 levels in non-malignant gyneco-
logical diseases were signiﬁcantly lower than those in malignant
diseases [6].
There is two case report with elevated levels of CA 19-9 and CA
125 in hydrometrocolpos due to imperforated hymen which is a
benign condition [7,8]. Both reported cases were in premenarcheal
age group and the levels were both higher than our case.
This is the ﬁrst incident reported in literature in the neonatal
period presenting with hydrometrocolpos and elevated levels of
CA 19-9 and CA 125. Hydrometrocolpos is a rare benign condition
which may be kept in mind in girl newborn baby with abdominal
mass and associated with high CA 19-9 and CA 125 levels.
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